SUD 0.00% 4.2¢ suda pharmaceuticals ltd

Is Aytu BioScience (AYTU) Building Another Arbor Pharmaceuticals?. Investors Say Yes, page-3

  1. 2,412 Posts.
    lightbulb Created with Sketch. 64
    says it all


    By being better, ZolpiMist® is in a position to earn a sizable portion of the sleep-aid market by standing alone as the only fast-acting oral spray of zolpidem tartrate, the most commonly prescribed sleep aid and the same ingredient found in Ambien. And, because of its unique route of administration, ZolpiMist® carries multiple benefits over its competition, in this case, Ambien. In fact, ZolpiMist® does what Ambien® can't provide- a more rapid onset of action through absorption in the oral mucosa, eliminating the time necessary for Ambien to metabolize through the liver. And, don't underestimate another important characteristic of ZolpiMist®...it also serves a large market by simplifying dosing for those patients who have difficulties swallowing pills.
 
watchlist Created with Sketch. Add SUD (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.